Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Paoletti

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Current Opinion in Pharmacology|January 21, 2015
Editorial overview: neurosciences: targeting glutamatergic signaling in CNS diseases: new hopes?Pierre Paoletti, Jean-Philippe Pin
Neuroscience|April 26, 2025
Editorial - Philippe Ascher (1936-2022)Jon W Johnson, Pierre Paoletti
Neuron|April 26, 2005
Modulation of triheteromeric NMDA receptors by N-terminal domain ligandsChristopher J Hatton, Pierre Paoletti
The Journal of Physiology|August 2, 2021
Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potentialChloé Geoffroy, Pierre Paoletti, Laetitia Mony
Nature|November 8, 2022
Remembering a giant of neurosciencePierre Paoletti, Alain Trautmann, Alain Marty
Trends in Neurosciences|May 29, 2023
Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signalingSimon Bossi, Lara Pizzamiglio, Pierre Paoletti
Neuron|December 8, 2022
Philippe Ascher (1936-2022)Pierre Paoletti, Alain Trautmann, Alain Marty
Neuropharmacology|May 31, 2021
Glycine agonism in ionotropic glutamate receptorsDavid Stroebel, Laetitia Mony, Pierre Paoletti
Neuropharmacology|June 12, 2016
Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutationsBenjamin Serraz, Teddy Grand, Pierre Paoletti
Current Opinion in Physiology|April 24, 2018
Triheteromeric NMDA receptors: from structure to synaptic physiologyDavid Stroebel, Mariano Casado, Pierre Paoletti
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Current Opinion in Pharmacology|January 21, 2015
Editorial overview: neurosciences: targeting glutamatergic signaling in CNS diseases: new hopes?Pierre Paoletti, Jean-Philippe Pin
Neuroscience|April 26, 2025
Editorial - Philippe Ascher (1936-2022)Jon W Johnson, Pierre Paoletti
Neuron|April 26, 2005
Modulation of triheteromeric NMDA receptors by N-terminal domain ligandsChristopher J Hatton, Pierre Paoletti
The Journal of Physiology|August 2, 2021
Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potentialChloé Geoffroy, Pierre Paoletti, Laetitia Mony
Nature|November 8, 2022
Remembering a giant of neurosciencePierre Paoletti, Alain Trautmann, Alain Marty
Trends in Neurosciences|May 29, 2023
Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signalingSimon Bossi, Lara Pizzamiglio, Pierre Paoletti
Neuron|December 8, 2022
Philippe Ascher (1936-2022)Pierre Paoletti, Alain Trautmann, Alain Marty
Neuropharmacology|May 31, 2021
Glycine agonism in ionotropic glutamate receptorsDavid Stroebel, Laetitia Mony, Pierre Paoletti
Neuropharmacology|June 12, 2016
Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutationsBenjamin Serraz, Teddy Grand, Pierre Paoletti
Current Opinion in Physiology|April 24, 2018
Triheteromeric NMDA receptors: from structure to synaptic physiologyDavid Stroebel, Mariano Casado, Pierre Paoletti
Pageof 8